Mohammed H Uddin

12PUBLICATIONS
24CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer cell biologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 10, 2026
Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2Ar and NPM1-m AML.

Md Hafiz Uddin, Sandhya Dhiman, Yufen Han

|Jan 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.

Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil

|Jan 08, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.

Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan

|Dec 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Md Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan

|Apr 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel

Pageof 2